447 related articles for article (PubMed ID: 27310602)
1. Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.
Mussap M; Noto A; Fanos V
Expert Rev Mol Diagn; 2016 Aug; 16(8):869-81. PubMed ID: 27310602
[TBL] [Abstract][Full Text] [Related]
2. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
Gevi F; Zolla L; Gabriele S; Persico AM
Mol Autism; 2016; 7():47. PubMed ID: 27904735
[TBL] [Abstract][Full Text] [Related]
3. The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder.
Srikantha P; Mohajeri MH
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035684
[TBL] [Abstract][Full Text] [Related]
4. A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project.
Smith AM; Natowicz MR; Braas D; Ludwig MA; Ney DM; Donley ELR; Burrier RE; Amaral DG
Autism Res; 2020 Aug; 13(8):1270-1285. PubMed ID: 32558271
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.
Diémé B; Mavel S; Blasco H; Tripi G; Bonnet-Brilhault F; Malvy J; Bocca C; Andres CR; Nadal-Desbarats L; Emond P
J Proteome Res; 2015 Dec; 14(12):5273-82. PubMed ID: 26538324
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study.
Rangel-Huerta OD; Gomez-Fernández A; de la Torre-Aguilar MJ; Gil A; Perez-Navero JL; Flores-Rojas K; Martín-Borreguero P; Gil-Campos M
Metabolomics; 2019 Jun; 15(7):99. PubMed ID: 31250215
[TBL] [Abstract][Full Text] [Related]
7. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.
Ristori MV; Mortera SL; Marzano V; Guerrera S; Vernocchi P; Ianiro G; Gardini S; Torre G; Valeri G; Vicari S; Gasbarrini A; Putignani L
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872562
[TBL] [Abstract][Full Text] [Related]
8. Profiles of urine and blood metabolomics in autism spectrum disorders.
Likhitweerawong N; Thonusin C; Boonchooduang N; Louthrenoo O; Nookaew I; Chattipakorn N; Chattipakorn SC
Metab Brain Dis; 2021 Oct; 36(7):1641-1671. PubMed ID: 34338974
[TBL] [Abstract][Full Text] [Related]
9. Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders.
Kang DW; Ilhan ZE; Isern NG; Hoyt DW; Howsmon DP; Shaffer M; Lozupone CA; Hahn J; Adams JB; Krajmalnik-Brown R
Anaerobe; 2018 Feb; 49():121-131. PubMed ID: 29274915
[TBL] [Abstract][Full Text] [Related]
10. Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy.
Kang DW; Adams JB; Vargason T; Santiago M; Hahn J; Krajmalnik-Brown R
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087514
[TBL] [Abstract][Full Text] [Related]
11. Metabolic perturbance in autism spectrum disorders: a metabolomics study.
Ming X; Stein TP; Barnes V; Rhodes N; Guo L
J Proteome Res; 2012 Dec; 11(12):5856-62. PubMed ID: 23106572
[TBL] [Abstract][Full Text] [Related]
12. Targeted metabolomics highlights perturbed metabolism in the brain of autism spectrum disorder sufferers.
Graham SF; Turkoglu O; Yilmaz A; Ustun I; Ugur Z; Bjorndhal T; Han B; Mandal R; Wishart D; Bahado-Singh RO
Metabolomics; 2020 Apr; 16(5):59. PubMed ID: 32333121
[TBL] [Abstract][Full Text] [Related]
13. Identification of metabolic pathway disturbances using multimodal metabolomics in autistic disorders in a Middle Eastern population.
Bitar T; Mavel S; Emond P; Nadal-Desbarats L; Lefèvre A; Mattar H; Soufia M; Blasco H; Vourc'h P; Hleihel W; Andres CR
J Pharm Biomed Anal; 2018 Apr; 152():57-65. PubMed ID: 29414019
[TBL] [Abstract][Full Text] [Related]
14. Untargeted Metabolomics Screen of Mid-pregnancy Maternal Serum and Autism in Offspring.
Ritz B; Yan Q; Uppal K; Liew Z; Cui X; Ling C; Inoue K; von Ehrenstein O; Walker DI; Jones DP
Autism Res; 2020 Aug; 13(8):1258-1269. PubMed ID: 32496662
[TBL] [Abstract][Full Text] [Related]
15. Alterations in Gut Vitamin and Amino Acid Metabolism are Associated with Symptoms and Neurodevelopment in Children with Autism Spectrum Disorder.
Zhu J; Hua X; Yang T; Guo M; Li Q; Xiao L; Li L; Chen J; Li T
J Autism Dev Disord; 2022 Jul; 52(7):3116-3128. PubMed ID: 34263410
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.
West PR; Amaral DG; Bais P; Smith AM; Egnash LA; Ross ME; Palmer JA; Fontaine BR; Conard KR; Corbett BA; Cezar GG; Donley EL; Burrier RE
PLoS One; 2014; 9(11):e112445. PubMed ID: 25380056
[TBL] [Abstract][Full Text] [Related]
17. Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.
Smith AM; King JJ; West PR; Ludwig MA; Donley ELR; Burrier RE; Amaral DG
Biol Psychiatry; 2019 Feb; 85(4):345-354. PubMed ID: 30446206
[TBL] [Abstract][Full Text] [Related]
18. The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders.
Hughes HK; Rose D; Ashwood P
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):81. PubMed ID: 30251184
[TBL] [Abstract][Full Text] [Related]
19. A metabolomics approach to investigate urine levels of neurotransmitters and related metabolites in autistic children.
Gevi F; Belardo A; Zolla L
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165859. PubMed ID: 32512190
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
Rose S; Niyazov DM; Rossignol DA; Goldenthal M; Kahler SG; Frye RE
Mol Diagn Ther; 2018 Oct; 22(5):571-593. PubMed ID: 30039193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
